Concord Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05K | Sell |
2
-1,999
| -100% | -$1.05M | ﹤0.01% | 753 |
|
|
2025
Q1 | $1.27M | Buy |
2,001
+739
| +59% | +$469K | 0.21% | 103 |
|
|
2024
Q4 | $899K | Buy |
1,262
+273
| +28% | +$194K | 0.15% | 108 |
|
|
2024
Q3 | $1.04M | Buy |
989
+89
| +10% | +$93.6K | 0.17% | 96 |
|
|
2024
Q2 | $946K | Buy |
900
+370
| +70% | +$389K | 0.17% | 104 |
|
|
2024
Q1 | $510K | Buy |
530
+49
| +10% | +$47.2K | 0.09% | 137 |
|
|
2023
Q4 | $422K | Buy |
481
+421
| +702% | +$370K | 0.08% | 141 |
|
|
2023
Q3 | $49.4K | Sell |
60
-291
| -83% | -$239K | 0.01% | 380 |
|
|
2023
Q2 | $252K | Buy |
351
+145
| +70% | +$104K | 0.05% | 174 |
|
|
2023
Q1 | $169K | Buy |
206
+33
| +19% | +$27.1K | 0.05% | 187 |
|
|
2022
Q4 | $125K | Buy |
+173
| New | +$125K | 0.04% | 218 |
|
|
2022
Q3 | – | Sell |
-241
| Closed | -$142K | – | 908 |
|
|
2022
Q2 | $142K | Buy |
241
+83
| +53% | +$48.9K | 0.04% | 209 |
|
|
2022
Q1 | $110K | Buy |
158
+8
| +5% | +$5.57K | 0.03% | 287 |
|
|
2021
Q4 | $95K | Buy |
150
+135
| +900% | +$85.5K | 0.02% | 316 |
|
|
2021
Q3 | $9K | Sell |
15
-98
| -87% | -$58.8K | ﹤0.01% | 486 |
|
|
2021
Q2 | $63K | Buy |
113
+12
| +12% | +$6.69K | 0.02% | 314 |
|
|
2021
Q1 | $48K | Buy |
+101
| New | +$48K | 0.02% | 347 |
|